PLASMIC score
Likelihood of severe ADAMTS13 deficiency (TTP) in thrombotic microangiopathy
- Onkopedia TMA (DGHO)
Sources last checked: 2026-10-13
PLASMIC score
Likelihood of severe ADAMTS13 deficiency (TTP) in thrombotic microangiopathy
Probability of severe ADAMTS13 deficiency 0–4 %.
Use only once microangiopathic haemolytic anaemia with thrombocytopenia is established. A bridge until ADAMTS13 activity is available — not a diagnosis of TTP.
Interpretation
| 0–4 — low | Probability of severe ADAMTS13 deficiency 0–4 %. |
|---|---|
| 5 — intermediate | Probability 5–24 %. |
| 6–7 — high | Probability 62–82 %; TTP is likely — a haematological emergency. Confirmation rests on ADAMTS13 activity, for which the score is designed as a bridge. |
What is the PLASMIC score?
The PLASMIC score estimates the probability of severe ADAMTS13 deficiency — the hallmark of thrombotic thrombocytopenic purpura (TTP) — in adults with thrombotic microangiopathy. It awards one point each for platelets < 30 ×10⁹/L, haemolysis, no active cancer, no transplant, MCV < 90 fL, INR < 1.5 and creatinine < 2.0 mg/dL. It was derived and externally validated by Bendapudi and colleagues in 2017 in the Harvard TMA registry.
When to use it
- In adults with microangiopathic haemolytic anaemia and thrombocytopenia while ADAMTS13 activity is pending
- As an early estimate of TTP likelihood while plasma exchange and immunotherapy for suspected immune TTP are being discussed
- Where ADAMTS13 testing is slow or unavailable
When not to use it
- Before microangiopathic haemolysis with thrombocytopenia has been established
- As a replacement for ADAMTS13 testing, which remains the diagnostic standard
- In children, where it has not been validated
How it is calculated
| Criterion | Points |
|---|---|
| Platelet count < 30 ×10⁹/L | +1 |
| Haemolysis: reticulocytes > 2.5 %, or haptoglobin undetectable, or indirect bilirubin > 2 mg/dL | +1 |
| No active cancer | +1 |
| No history of solid-organ or stem-cell transplantation | +1 |
| MCV < 90 fL | +1 |
| INR < 1.5 | +1 |
| Creatinine < 2.0 mg/dL | +1 |
Clinical pearls and limitations
- Use only once microangiopathic haemolytic anaemia with thrombocytopenia is established. A bridge until ADAMTS13 activity is available — not a diagnosis of TTP.
- Creatinine < 2.0 mg/dL (≈ 177 µmol/L) favours TTP; marked renal failure points to HUS.
- INR < 1.5 helps separate TTP from DIC; MCV < 90 fL helps exclude B12/folate deficiency and MDS.
- The French TMA score is an alternative with fewer items.
Frequently asked questions
What PLASMIC score suggests TTP?
6–7 points: 62–82 % probability of severe ADAMTS13 deficiency. 5 points is intermediate (5–24 %), 0–4 is low (0–4 %).
Can I use µmol/L for creatinine?
The score is defined in mg/dL. 2.0 mg/dL is about 177 µmol/L (divide µmol/L by 88.4 to get mg/dL).
Does a low PLASMIC score rule out TTP?
It makes severe ADAMTS13 deficiency unlikely, but the score has limited sensitivity and specificity — ADAMTS13 activity remains the diagnostic standard whenever TTP is suspected.
Evidence and guidelines
- Primary source: Bendapudi PK, Hurwitz S, Fry A, et al. Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study. Lancet Haematol 2017;4(4):e157-e164.
- Onkopedia (DGHO): Thrombotische Mikroangiopathie (TMA) — Tabelle 3, PLASMIC-Score.
Have a follow-up question?
Medelix answers clinical questions from current guidelines and studies — every statement with its source.
Ask Medelix about the PLASMIC scoreRelated calculators
Embed this calculatorFree to use on your website, intranet or teaching page. Copy the code below.
<iframe src="https://medelix.ai/en/embed/plasmic" title="PLASMIC score – Medelix" width="100%" height="620" style="border:0;max-width:720px" loading="lazy"></iframe>
<p><a href="https://medelix.ai/en/calculators/plasmic-score">PLASMIC score calculator by Medelix</a></p>For healthcare professionals and medical students. These tools support, and do not replace, clinical judgement. Always check results against the original source and your local protocols.